WO2024113150A1 - Composition for caring for keratin materials - Google Patents
Composition for caring for keratin materials Download PDFInfo
- Publication number
- WO2024113150A1 WO2024113150A1 PCT/CN2022/134956 CN2022134956W WO2024113150A1 WO 2024113150 A1 WO2024113150 A1 WO 2024113150A1 CN 2022134956 W CN2022134956 W CN 2022134956W WO 2024113150 A1 WO2024113150 A1 WO 2024113150A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- composition according
- active ingredient
- salt type
- gum
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 78
- 102000011782 Keratins Human genes 0.000 title claims abstract description 28
- 108010076876 Keratins Proteins 0.000 title claims abstract description 28
- 239000000463 material Substances 0.000 title claims abstract description 28
- 239000004480 active ingredient Substances 0.000 claims abstract description 31
- 150000003839 salts Chemical class 0.000 claims abstract description 31
- 229920002444 Exopolysaccharide Polymers 0.000 claims abstract description 27
- 239000002537 cosmetic Substances 0.000 claims abstract description 27
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 22
- 239000000230 xanthan gum Substances 0.000 claims abstract description 18
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 18
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 18
- 239000008346 aqueous phase Substances 0.000 claims abstract description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 10
- 229920002310 Welan gum Polymers 0.000 claims description 9
- 229920002148 Gellan gum Polymers 0.000 claims description 7
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 6
- 229960005055 sodium ascorbate Drugs 0.000 claims description 6
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 6
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 6
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 5
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 5
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 5
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 5
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical group [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 5
- 159000000003 magnesium salts Chemical class 0.000 claims description 4
- 159000000001 potassium salts Chemical class 0.000 claims description 4
- 238000002560 therapeutic procedure Methods 0.000 claims description 4
- 150000003751 zinc Chemical class 0.000 claims description 4
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 239000001540 sodium lactate Substances 0.000 claims description 3
- 229940005581 sodium lactate Drugs 0.000 claims description 3
- 235000011088 sodium lactate Nutrition 0.000 claims description 3
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 claims description 3
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 claims description 3
- GEYJUFBPCGDENK-UHFFFAOYSA-M sodium;3,8-dimethyl-5-propan-2-ylazulene-1-sulfonate Chemical compound [Na+].CC(C)C1=CC=C(C)C2=C(S([O-])(=O)=O)C=C(C)C2=C1 GEYJUFBPCGDENK-UHFFFAOYSA-M 0.000 claims description 3
- 239000011670 zinc gluconate Substances 0.000 claims description 3
- 235000011478 zinc gluconate Nutrition 0.000 claims description 3
- 229960000306 zinc gluconate Drugs 0.000 claims description 3
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000007764 o/w emulsion Substances 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 210000003491 skin Anatomy 0.000 description 20
- 239000003921 oil Substances 0.000 description 18
- 241000894006 Bacteria Species 0.000 description 13
- 238000000855 fermentation Methods 0.000 description 9
- 230000004151 fermentation Effects 0.000 description 9
- 239000012071 phase Substances 0.000 description 7
- 241000736131 Sphingomonas Species 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 235000012149 noodles Nutrition 0.000 description 5
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 125000001153 fluoro group Chemical group F* 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000790234 Sphingomonas elodea Species 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 3
- 159000000007 calcium salts Chemical class 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000000216 gellan gum Substances 0.000 description 3
- 235000010492 gellan gum Nutrition 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- 241000588986 Alcaligenes Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-JFNONXLTSA-N L-mannopyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-JFNONXLTSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 150000004044 tetrasaccharides Chemical group 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- WECIKJKLCDCIMY-UHFFFAOYSA-N 2-chloro-n-(2-cyanoethyl)acetamide Chemical compound ClCC(=O)NCCC#N WECIKJKLCDCIMY-UHFFFAOYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- NOLVNUOQUJETRB-NCZNAIGRSA-N C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O NOLVNUOQUJETRB-NCZNAIGRSA-N 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical group C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 229910018557 Si O Inorganic materials 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 241000131972 Sphingomonadaceae Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241000589634 Xanthomonas Species 0.000 description 1
- 241001517672 Xanthomonas axonopodis pv. begoniae Species 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- 241000321047 Xanthomonas campestris pv. carotae Species 0.000 description 1
- 241000321050 Xanthomonas campestris pv. incanae Species 0.000 description 1
- 241001668516 Xanthomonas citri subsp. malvacearum Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 229920001586 anionic polysaccharide Polymers 0.000 description 1
- 150000004836 anionic polysaccharides Chemical class 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000004534 cecum Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 229940082491 opUNTia ficus-indica flower extract Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Inorganic materials [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Definitions
- the skin is the protective barrier for the human body. It protects the interior of the body from physical injury (such as trauma) and biological injury (such as bacteria, viruses or fungi) .
- the epidermis is a keratinized stratified pavimentous epithelium. Its mean thickness ranges from 60 to 100 ⁇ m and may reach 600 to 700 ⁇ m on the sole of the feet and the palm of the hands. It consists mainly of keratinocytes, but also other cells, and rests on a basal membrane that separates it from the dermis.
- the skin undergoes changes in all its compartments, i.e. dermal and epidermal.
- the development of formulations dedicated to caring for the skin is permanent.
- Some cosmetic products comprise active ingredients of salt type for caring for the skin.
- active ingredients of salt type for caring for the skin.
- dipotassium glycyrrhizate, magnesium sulfate, and low molecular weight sodium hyaluronate can be used as active ingredients of salt type.
- compositions for caring for keratin materials comprising a relatively higher amount of active ingredients of salt type, the salt contained therein can suspend in the system stably and there is no noodling risk.
- the present invention provides a composition for caring for keratin materials comprising in an aqueous phase:
- composition according to the present invention can be used to care for the keratin materials due to the presence of the at least one cosmetic active ingredient of salt type.
- composition according to the present invention will not have noodling issue upon application to keratin materials and the salt contained therein will suspend in the system stably.
- the present invention provides a non-therapeutic method for caring for keratin materials, comprising applying the composition according to the first aspect of the present invention to the keratin materials.
- keratin materials is intended to cover the hair, human skin, and mucous membranes such as the lips. Facial skin is most particularly considered according to the present invention.
- composition for caring for keratin materials according to the present invention comprises in an aqueous phase:
- the composition of the present invention comprises xanthan gum.
- Xanthan gum is a high molecular weight polysaccharide or hydrophilic colloid (also known as a gum) that is produced by fermentation of various species of the Xanthomonas, such as X. carotae, X. campestris, X. incanae, X. begoniae and X. malvacearum.
- Xanthan gum may comprise in their structure three different monosaccharides, namely mannose, glucose and glucuronic acid, in salt form, such as in the form of the sodium salt.
- Xanthan gum may have, for example, a viscosity ranging from 800 to 2000 cps for an aqueous composition containing 1%KCl and 1%xanthan gum (measured at 25°C. using a Brookfield viscometer, type LVT at 60 rpm) . It has a molecular weight ranging, for example, from 1 000 000 to 50 000 000.
- Xanthane gums which are more particularly preferred are KELTROL marketed by KELCO, a 1%aqueous solution, 1%KCL of which has a Brookfield LVT viscosity at 60 rpm of 800 to 1700 cps, KELZAN S marketed by KELCO, a 1%aqueous solution of which has a Brookfield LVT viscosity at 60 rpm of 1000 cP, Rhodopol 23, 23 U, and 23 C marketed by Rhone-Poulenc, a 1%aqueous solution with 1%KCl of which has a Brookfield LVT viscosity at 60 rpm of 1200-1800 cps, Deuteron XG marketed by Schoner GmbH., a 1%aqueous solution of which has a Brookfield LVT viscosity at 30 rpm of 2400 cps, and Actigum CX9 marketed by CECA, a 1%aqueous solution of which has a Brookfield LVT viscos
- xanthum gum is present in the composition according to the present invention in an amount ranging from 0.05 wt. %to 0.5 wt. %, preferably from 0.15 wt. %to 0.3 wt. %, relative to the total weight of the composition.
- the composition according to the present invention comprises at least one sphingan exopolysaccharide.
- Sphingans are biogums which can be produced by bacteria of the genus Sphingomonas.
- Sphingans are structurally closely related bacterial exopolysaccharides produced by members of the genus Sphingomonas. Sphingan expolysaccharides can be produced, i.e. are obtainable, by fermentation of a carbohydrate by bacteria of the genus Sphingomonas. The most commonly known sphingans include gellan, welan, rhamsan and diutan and these exhibit excellent rheological properties. Sphingans are structurally related by a backgone that comprises the sugars D-glucose, D-glucuronic acid and L-rhamnose (or L-mannose) but differ in the nature and location of their side-chains and in the presence or absence of acyl groups.
- the at least one sphingan exopolysaccharide can be chosen from the group consisting of gellan, welan, diutan gum and mixtures thereof.
- the at least one sphingan exopolysaccharide can be selected from gellan, welan and diutan gum, or combination thereof.
- Welan gum is a biogum which can be produced by fermentation of bacteria from the genus Alcaligenes or the genus Sphingomonas. More specifically, welan gum is an exopolysaccharide that can be produced, i.e. is obtainable, by fermentation of a carbohydrate by bacteria from the genus Alcaligenes or the genus Sphingomonas.
- Welan gum is a polymer that has a repeating tetrasaccharide backbone chain containing L-mannose, L-rhamnose, D-glucose, and D-glucuronic acid. In one particular embodiment, the welan gum is obtained by fermentation of a carbohydrate by bacteria from genus Sphingomonas.
- Gellan gum is a biogum which can be produced by fermentation of bacteria of the species Sphingomonas elodea.
- Gellan gum is a water-soluble anionic polysaccharide produced by the bacterium Sphingomonas elodea. More specifically, gellan gum is an exopolysaccharide that can be produced, i.e. is obtainable, by fermentation of a carbohydrate by bacteria of the species Sphingomonas elodea. It is a polymer which has, as a repeating unit, a tetrasaccharide which consists of two residues of D-glucose and one of each residue of L-rhamnose and D-glucuronic acid.
- Diutan gum also known as heteropolysaccharide S-657, is a biogum which is produced by fermentation of a bacteria strain from genus Shingomonas, for example, a bacteria strain from genus Shingomonas deposited in the American Type Culture Collection (ATCC) with deposit number ATCC 53159. More specifically, diutan gum is an exopolysaccharide that can be produced, i.e. is obtainable, by fermentation of a carbohydrate by bacteria from the genus Shingomonas, and, in particular, a bacteria strain from genus Shingomonas having a deposit number ATCC 53159.
- ATCC American Type Culture Collection
- Diutan generally exhibits a hexameric repeat unit consisting of four sugars in the backbone (glucose-glucuronic acid-glucose-rhamnose) and a side chain of two rhamnose residues attached to one of the glucose residues.
- One non-limiting example of commercially available diutan gum is Kelcocare TM diutan gum from CP Kelco.
- Diutan gum is also commonly referred as S-657 polysaccharide.
- the composition comprises a sphingan exopolysaccharide selected from welan, diutan gum or a combination thereof.
- the composition comprises diutan gum as sphingan exopolysaccharide.
- the sphingan exopolysaccharide is present in the composition according to the present invention in an amount ranging from 0.05 wt. %to 0.3 wt. %, preferably from 0.06 wt. %to 0.2 wt. %, relative to the total weight of the composition.
- the weight ratio of xanthan gum to the sphingan exopolysaccharide is between 1.3: 1 and 4: 1, preferably between 1.5: 1 and 3: 1.
- composition of the present invention comprises at least one cosmetic active ingredient of salt type.
- the cosmetic active ingredient of salt type is not particularly limited. It can be selected from active ingredients of salt type for caring for keratin materials such as the skin, such as anti-redness agents, anti-inflammation agents, and the like.
- active ingredients of salt type for caring for keratin materials such as the skin
- the cosmetic active ingredient of salt type is selected from sodium slats, potassium salts, magnesium salts, zinc salts, calcium salts, or their combinations, for caring for keratin materials such as the skin.
- sodium salts for caring for keratin materials such as the skin
- potassium salts for caring for keratin materials such as the skin
- magnesium salts for caring for keratin materials such as the skin mention can be made of magnesium sulfate, magnesium ascorbyl phophate, and the like.
- zinc salts for caring for keratin materials such as the skin
- calcium salts for caring for keratin materials such as the skin mention can be made of calcium chloride, and the like.
- the cosmetic active ingredient of salt type is selected from sodium hyaluronate, sodium pyrrolidone carboxylate, sodium lactate, sodium ascorbate phosphate, sodium azulene sulfonate, sodium ascorbate, dipotassium glycyrrhizate, magnesium sulfate, magnesium ascorbyl phophate, zinc gluconate, calcium chloride, or their combinations.
- the weight ratio of the sphingan exopolysaccharide to the cosmetic active ingredient of salt type is between 0.04: 1 and 0.2: 1, preferably between 0.05: 1 and 0.15: 1.
- composition of the present invention comprises an aqueous phase.
- Said aqueous phase comprises water.
- the aqueous phase comprises an organic solvent miscible with water (at room temperature 25°C) selected from ethanol, glycols and polyols having from 2 to 20 carbon atoms, preferably from 2 to 10 carbon atoms, and preferentially having from 2 to 6 carbon atoms, such as glycerin, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, caprylyl glycol, dipropylene glycol, diethylene glycol; and mixtures thereof, so as to provide a hydration effect.
- an organic solvent miscible with water selected from ethanol, glycols and polyols having from 2 to 20 carbon atoms, preferably from 2 to 10 carbon atoms, and preferentially having from 2 to 6 carbon atoms, such as glycerin, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, caprylyl glycol, dipropylene glycol, diethylene glycol; and
- water is present in the composition of the present invention in an amount ranging from 60 wt. %to 90 wt. %, preferably from 65 wt.%to 88 wt. %, relative to the total weight of the composition.
- composition of the present invention may comprise an oily phase.
- the oily phase contains at least one oil, notably a cosmetic oil. It may also contain other fatty substances.
- oil means a water-immiscible non-aqueous compound that is liquid at room temperature (20°C) and at atmospheric pressure (760 mmHg) .
- the oils may be volatile or non-volatile.
- non-volatile refers to an oil whose vapour pressure at room temperature and atmospheric pressure is non-zero and is less than 10 -3 mmHg (0.13 Pa) .
- volatile oil means any oil that is capable of evaporating on contact with the skin in less than one hour, at room temperature and atmospheric pressure.
- the oily phase may comprise hydrocarbon-based oils, silicone oils, fluoro oils or non-fluoro oils, or mixtures thereof.
- They may be of animal, plant, mineral or synthetic origin.
- silicon oil means an oil comprising at least one silicon atom, and notably at least one Si-O group.
- fluoro oil means an oil comprising at least one fluorine atom.
- hydrocarbon-based oil means an oil mainly containing hydrogen and carbon atoms.
- the oils may optionally comprise oxygen, nitrogen, sulfur and/or phosphorus atoms, for example in the form of hydroxyl or acid radicals.
- the oily phase is present in the composition of the present invention in an amount ranging from 0.1 wt. %to 20 wt. %, preferably from 0.5 wt. %to 10 wt. %, relative to the total weight of the composition of the present invention.
- the inventors have found that if there is an oil present in the composition according to the present invention, the oil will not leak out from the system.
- composition of the present invention may comprise an additional cosmetic active ingredient.
- moisturizing agents such as protein hydrolysates; botanical extracts (such as carica papaya fruit extract, hydrolyzed opuntia ficus-indica flower extract) ; vitamins such as vitamin A (retinol) , vitamin E (tocopherol) , vitamin C (ascorbic acid) , and derivatives of said vitamins (in particular esters) and mixtures thereof; urea; caffeine; tightening agents; agents acting on the microcirculation, and mixtures thereof.
- moisturizing agents such as protein hydrolysates; botanical extracts (such as carica papaya fruit extract, hydrolyzed opuntia ficus-indica flower extract) ; vitamins such as vitamin A (retinol) , vitamin E (tocopherol) , vitamin C (ascorbic acid) , and derivatives of said vitamins (in particular esters) and mixtures thereof; urea; caffeine; tightening agents; agents acting on the microcirculation, and mixtures thereof.
- composition of the present invention may also contain conventional cosmetic adjuvants or additives, for instance, pH regulators, surfactants, other thickeners, and mixtures thereof.
- the present invention provides a composition for caring for the skin comprising in an aqueous phase, relative to the total weight of the composition:
- weight ratio of xanthan to the sphingan exopolysaccharide is between 1.3: 1 and 4: 1;
- the weight ratio of the sphingan exopolysaccharide to the cosmetic active ingredient of salt type is between 0.04: 1 and 0.2: 1.
- composition of the present invention can be in the form of an oil-in-water emulsion or a homogeneous hydrous system.
- composition of the present invention can be used for caring for keratin materials, especially the skin.
- the present invention provides a non-therapeutic method for caring for the skin, comprising applying the composition according to the first aspect of the present invention to keratin materials, especially the skin.
- compositions of invention examples (IE) 1-5 and comparative examples (CE) 1-5 were prepared based on the amounts given in Table 2. The amounts are given in%by weight of active ingredient relative to the total weight of the composition.
- compositions listed above were prepared as follows, taking the composition of invention example 1 as an example:
- the suspension property of a composition to be tested was evaluated as follows.
- the centrifuged sample was compared with the original sample in terms of appearance. If the centrifuged sample is identical to the original sample (even phase) , it will be considered as passing the suspension test. If the centrifuged sample is different from the original sample (for example separated into two phases or sediment occurs) , it will be considered as failing for the suspension test.
- the noodling risk of each composition prepared was evaluated by one sensory expert through special gesture as below:
- composition of the present invention can pass the suspension test and has no noodling risk.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
A composition for caring for keratin materials comprises an aqueous phase: (i) xanthan gum; (ii) at least one sphingan exopolysaccharide; and (iii) at least 0.5 mmol/L of at least one cosmetic active ingredient of salt type, relative to the total volume of the composition.
Description
The present invention relates to a cosmetic composition. In particular, the present invention relates to a composition for caring for keratin materials. The present invention also relates to a non-therapeutic method for caring for keratin materials.
BACKGROUND ART
The skin is the protective barrier for the human body. It protects the interior of the body from physical injury (such as trauma) and biological injury (such as bacteria, viruses or fungi) . The epidermis is a keratinized stratified pavimentous epithelium. Its mean thickness ranges from 60 to 100μm and may reach 600 to 700μm on the sole of the feet and the palm of the hands. It consists mainly of keratinocytes, but also other cells, and rests on a basal membrane that separates it from the dermis.
During the menopause, the skin undergoes changes in all its compartments, i.e. dermal and epidermal. The development of formulations dedicated to caring for the skin is permanent.
Some cosmetic products comprise active ingredients of salt type for caring for the skin. For example, dipotassium glycyrrhizate, magnesium sulfate, and low molecular weight sodium hyaluronate, can be used as active ingredients of salt type.
However, for some cosmetic products comprising a relatively higher amount of active ingredients of salt type, it will be difficult for the salt to suspend in the system stably; meanwhile there will be noodling risk.
Thus, there is still a need to formulate a composition for caring for keratin materials comprising a relatively higher amount of active ingredients of salt type, the salt contained therein can suspend in the system stably and there is no noodling risk.
SUMMARY OF THE INVENTION
The inventors have now discovered that it is possible to formulate compositions for caring for keratin materials comprising a relatively higher amount of active ingredients of salt type, the salt contained therein can suspend in the system stably and there is no noodling risk.
Accordingly, in a first aspect, the present invention provides a composition for caring for keratin materials comprising in an aqueous phase:
(i) xanthan gum;
(ii) at least one sphingan exopolysaccharide; and
(iii) at least 0.5 mmol/L of at least one cosmetic active ingredient of salt type, relative to the total volume of the composition.
The composition according to the present invention can be used to care for the keratin materials due to the presence of the at least one cosmetic active ingredient of salt type.
The inventors have found that the composition according to the present invention will not have noodling issue upon application to keratin materials and the salt contained therein will suspend in the system stably.
In a second aspect, the present invention provides a non-therapeutic method for caring for keratin materials, comprising applying the composition according to the first aspect of the present invention to the keratin materials.
Other advantages of the present invention will emerge more clearly on reading the description and the examples that follow.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the art the present invention belongs to. When the definition of a term in the present description conflicts with the meaning as commonly understood by those skilled in the art the present invention belongs to, the definition described herein shall apply.
In that which follows and unless otherwise indicated, the limits of a range of values are included within this range, in particular in the expressions "between... and…" and "from... to... " .
Moreover, the expression "at least one" used in the present description is equivalent to the expression "one or more" .
Throughout the instant application, the term “comprising” is to be interpreted as encompassing all specifically mentioned features as well as optional, additional, unspecified ones. As used herein, the use of the term “comprising” also discloses the embodiment wherein no features other than the specifically mentioned features are present (i.e. “consisting of” ) .
Unless otherwise specified, all numerical values expressing amount of ingredients and the like which are used in the description and claims are to be understood as being modified by the term “about” . Accordingly, unless indicated to the contrary, the numerical values and parameters described herein are approximate values which are capable of being changed according to the desired purpose as required.
For the purposes of the present invention, the term “keratin materials” is intended to cover the hair, human skin, and mucous membranes such as the lips. Facial skin is most particularly considered according to the present invention.
All percentages in the present invention refer to weight percentage, unless otherwise specified.
The composition for caring for keratin materials according to the present invention comprises in an aqueous phase:
(i) xanthan gum;
(ii) at least one sphingan exopolysaccharide; and
(iii) at least 0.5 mmol/L of at least one cosmetic active ingredient of salt type, relative to the total volume of the composition.
Xanthan gum
According to the first aspect, the composition of the present invention comprises xanthan gum.
Xanthan gum is a high molecular weight polysaccharide or hydrophilic colloid (also known as a gum) that is produced by fermentation of various species of the Xanthomonas, such as X. carotae, X. campestris, X. incanae, X. begoniae and X. malvacearum. Xanthan gum may comprise in their structure three different monosaccharides, namely mannose, glucose and glucuronic acid, in salt form, such as in the form of the sodium salt.
Xanthan gum may have, for example, a viscosity ranging from 800 to 2000 cps for an aqueous composition containing 1%KCl and 1%xanthan gum (measured at 25℃. using a Brookfield viscometer, type LVT at 60 rpm) . It has a molecular weight ranging, for example, from 1 000 000 to 50 000 000.
Xanthane gums which are more particularly preferred are KELTROL marketed by KELCO, a 1%aqueous solution, 1%KCL of which has a Brookfield LVT viscosity at 60 rpm of 800 to 1700 cps, KELZAN S marketed by KELCO, a 1%aqueous solution of which has a Brookfield LVT viscosity at 60 rpm of 1000 cP, Rhodopol 23, 23 U, and 23 C marketed by Rhone-Poulenc, a 1%aqueous solution with 1%KCl of which has a Brookfield LVT viscosity at 60 rpm of 1200-1800 cps, Deuteron XG marketed by Schoner GmbH., a 1%aqueous solution of which has a Brookfield LVT viscosity at 30 rpm of 2400 cps, and Actigum CX9 marketed by CECA, a 1%aqueous solution of which has a Brookfield LVT viscosity at 30 rpm of 1200 cps, KELZAN K9 C57 marketed by KELCO, a 11%aqueous solution of which has a Brookfield LVT viscosity at 60 rpm of 630 to 1,000 cP.
Advantageously, xanthum gum is present in the composition according to the present invention in an amount ranging from 0.05 wt. %to 0.5 wt. %, preferably from 0.15 wt. %to 0.3 wt. %, relative to the total weight of the composition.
Sphingan exopolysaccharides
According to the first aspect, the composition according to the present invention comprises at least one sphingan exopolysaccharide.
The terms “sphingan exopolysaccharide” and “sphingan” are used interchangeably herein. Sphingans are biogums which can be produced by bacteria of the genus Sphingomonas.
Sphingans are structurally closely related bacterial exopolysaccharides produced by members of the genus Sphingomonas. Sphingan expolysaccharides can be produced, i.e. are obtainable, by fermentation of a carbohydrate by bacteria of the genus Sphingomonas. The most commonly known sphingans include gellan, welan, rhamsan and diutan and these exhibit excellent rheological properties. Sphingans are structurally related by a backgone that comprises the sugars D-glucose, D-glucuronic acid and L-rhamnose (or L-mannose) but differ in the nature and location of their side-chains and in the presence or absence of acyl groups. Details of the structures of sphingans can be found in the literature, for instance in a book by Glaeser S.P., Kampfer P. (2014) The Family Sphingomonadaceae, and in Rosenberg E., DeLong E.F., Lory S., Stackebrandt E., Thompson F. (eds) , The Prokaryotes, Springer, Berlin, Heidelberg. The at least one sphingan exopolysaccharide can be chosen from the group consisting of gellan, welan, diutan gum and mixtures thereof.
Preferably, the at least one sphingan exopolysaccharide can be selected from gellan, welan and diutan gum, or combination thereof.
Welan gum is a biogum which can be produced by fermentation of bacteria from the genus Alcaligenes or the genus Sphingomonas. More specifically, welan gum is an exopolysaccharide that can be produced, i.e. is obtainable, by fermentation of a carbohydrate by bacteria from the genus Alcaligenes or the genus Sphingomonas. Welan gum is a polymer that has a repeating tetrasaccharide backbone chain containing L-mannose, L-rhamnose, D-glucose, and D-glucuronic acid. In one particular embodiment, the welan gum is obtained by fermentation of a carbohydrate by bacteria from genus Sphingomonas.
Gellan gum is a biogum which can be produced by fermentation of bacteria of the species Sphingomonas elodea. Gellan gum is a water-soluble anionic polysaccharide produced by the bacterium Sphingomonas elodea. More specifically, gellan gum is an exopolysaccharide that can be produced, i.e. is obtainable, by fermentation of a carbohydrate by bacteria of the species Sphingomonas elodea. It is a polymer which has, as a repeating unit, a tetrasaccharide which consists of two residues of D-glucose and one of each residue of L-rhamnose and D-glucuronic acid.
Diutan gum, also known as heteropolysaccharide S-657, is a biogum which is produced by fermentation of a bacteria strain from genus Shingomonas, for example, a bacteria strain from genus Shingomonas deposited in the American Type Culture Collection (ATCC) with deposit number ATCC 53159. More specifically, diutan gum is an exopolysaccharide that can be produced, i.e. is obtainable, by fermentation of a carbohydrate by bacteria from the genus Shingomonas, and, in particular, a bacteria strain from genus Shingomonas having a deposit number ATCC 53159. Diutan generally exhibits a hexameric repeat unit consisting of four sugars in the backbone (glucose-glucuronic acid-glucose-rhamnose) and a side chain of two rhamnose residues attached to one of the glucose residues. One non-limiting example of commercially available diutan gum is Kelcocare
TM diutan gum from CP Kelco. Diutan gum is also commonly referred as S-657 polysaccharide.
More preferably, the composition comprises a sphingan exopolysaccharide selected from welan, diutan gum or a combination thereof.
Most preferably, the composition comprises diutan gum as sphingan exopolysaccharide.
Advantageously, the sphingan exopolysaccharide is present in the composition according to the present invention in an amount ranging from 0.05 wt. %to 0.3 wt. %, preferably from 0.06 wt. %to 0.2 wt. %, relative to the total weight of the composition.
Advantageously, the weight ratio of xanthan gum to the sphingan exopolysaccharide is between 1.3: 1 and 4: 1, preferably between 1.5: 1 and 3: 1.
Cosmetic active ingredient of salt type
According to the first aspect, the composition of the present invention comprises at least one cosmetic active ingredient of salt type.
The cosmetic active ingredient of salt type is not particularly limited. It can be selected from active ingredients of salt type for caring for keratin materials such as the skin, such as anti-redness agents, anti-inflammation agents, and the like.
As examples of active ingredients of salt type for caring for keratin materials such as the skin, mention can be made of sodium salts, potassium salts, magnesium salts, zinc salts, calcium salts, and so on.
Thus, according to some embodiments, the cosmetic active ingredient of salt type is selected from sodium slats, potassium salts, magnesium salts, zinc salts, calcium salts, or their combinations, for caring for keratin materials such as the skin.
In particular, as examples of sodium salts for caring for keratin materials such as the skin, mention can be made of sodium hyaluronate, sodium pyrrolidone carboxylate, sodium lactate, sodium ascorbate phosphate, sodium azulene sulfonate, sodium ascorbate, and the like.
As examples of potassium salts for caring for keratin materials such as the skin, mention can be made of dipotassium glycyrrhizate, and the like.
As examples of magnesium salts for caring for keratin materials such as the skin, mention can be made of magnesium sulfate, magnesium ascorbyl phophate, and the like.
As examples of zinc salts for caring for keratin materials such as the skin, mention can be made of zinc gluconate, and the like.
As examples of calcium salts for caring for keratin materials such as the skin, mention can be made of calcium chloride, and the like.
In some embodiments, the cosmetic active ingredient of salt type is selected from sodium hyaluronate, sodium pyrrolidone carboxylate, sodium lactate, sodium ascorbate phosphate, sodium azulene sulfonate, sodium ascorbate, dipotassium glycyrrhizate, magnesium sulfate, magnesium ascorbyl phophate, zinc gluconate, calcium chloride, or their combinations.
It is easy for the skilled in the art to adjust the amount of the cosmetic active ingredient of salt type based on the desired use of the composition according to the present invention.
Advantageously, the weight ratio of the sphingan exopolysaccharide to the cosmetic active ingredient of salt type is between 0.04: 1 and 0.2: 1, preferably between 0.05: 1 and 0.15: 1.
Aqueous phase
The composition of the present invention comprises an aqueous phase.
Said aqueous phase comprises water.
Optionally, the aqueous phase comprises an organic solvent miscible with water (at room temperature 25℃) selected from ethanol, glycols and polyols having from 2 to 20 carbon atoms, preferably from 2 to 10 carbon atoms, and preferentially having from 2 to 6 carbon atoms, such as glycerin, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, caprylyl glycol, dipropylene glycol, diethylene glycol; and mixtures thereof, so as to provide a hydration effect.
Advantageously, water is present in the composition of the present invention in an amount ranging from 60 wt. %to 90 wt. %, preferably from 65 wt.%to 88 wt. %, relative to the total weight of the composition.
Oily phase
The composition of the present invention may comprise an oily phase.
The oily phase contains at least one oil, notably a cosmetic oil. It may also contain other fatty substances.
The term “oil” means a water-immiscible non-aqueous compound that is liquid at room temperature (20℃) and at atmospheric pressure (760 mmHg) .
The oils may be volatile or non-volatile.
The term “non-volatile” refers to an oil whose vapour pressure at room temperature and atmospheric pressure is non-zero and is less than 10
-3 mmHg (0.13 Pa) .
For the purposes of the invention, the term "volatile oil" means any oil that is capable of evaporating on contact with the skin in less than one hour, at room temperature and atmospheric pressure.
The oily phase may comprise hydrocarbon-based oils, silicone oils, fluoro oils or non-fluoro oils, or mixtures thereof.
They may be of animal, plant, mineral or synthetic origin.
For the purposes of the present invention, the term “silicone oil” means an oil comprising at least one silicon atom, and notably at least one Si-O group.
The term "fluoro oil" means an oil comprising at least one fluorine atom.
The term "hydrocarbon-based oil" means an oil mainly containing hydrogen and carbon atoms.
The oils may optionally comprise oxygen, nitrogen, sulfur and/or phosphorus atoms, for example in the form of hydroxyl or acid radicals.
If presents, advantageously, the oily phase is present in the composition of the present invention in an amount ranging from 0.1 wt. %to 20 wt. %, preferably from 0.5 wt. %to 10 wt. %, relative to the total weight of the composition of the present invention.
The inventors have found that if there is an oil present in the composition according to the present invention, the oil will not leak out from the system.
Additional cosmetic active ingredients
The composition of the present invention may comprise an additional cosmetic active ingredient.
As examples of cosmetic active ingredient, mention can be made of moisturizing agents such as protein hydrolysates; botanical extracts (such as carica papaya fruit extract, hydrolyzed opuntia ficus-indica flower extract) ; vitamins such as vitamin A (retinol) , vitamin E (tocopherol) , vitamin C (ascorbic acid) , and derivatives of said vitamins (in particular esters) and mixtures thereof; urea; caffeine; tightening agents; agents acting on the microcirculation, and mixtures thereof.
It is easy for the skilled in the art to adjust the amount of the additional cosmetic active ingredient based on the final use of the composition according to the present invention.
Additional adjuvants or additives
The composition of the present invention may also contain conventional cosmetic adjuvants or additives, for instance, pH regulators, surfactants, other thickeners, and mixtures thereof.
The skilled in the art can select the amount of the additional adjuvants or additive so as not to adversely impact the final use of the composition according to the present invention.
According to a particularly preferred embodiment, the present invention provides a composition for caring for the skin comprising in an aqueous phase, relative to the total weight of the composition:
(i) from 0.15 wt. %to 0.3 wt. %of xanthan gum;
(ii) from 0.06 wt. %to 0.2 wt. %of diutan gum; and
(iii) at least 0.5 mmol/L of at least one active ingredient of salt type,
wherein the weight ratio of xanthan to the sphingan exopolysaccharide is between 1.3: 1 and 4: 1;
the weight ratio of the sphingan exopolysaccharide to the cosmetic active ingredient of salt type is between 0.04: 1 and 0.2: 1.
Galenic form and method
The composition of the present invention can be in the form of an oil-in-water emulsion or a homogeneous hydrous system.
The composition of the present invention can be used for caring for keratin materials, especially the skin.
According to the second aspect, the present invention provides a non-therapeutic method for caring for the skin, comprising applying the composition according to the first aspect of the present invention to keratin materials, especially the skin.
The following examples serve to illustrate the present invention without, however, being limiting in nature.
EXAMPLES
Main raw materials used, trade names and supplier thereof are listed in Table 1.
Table 1
Invention Examples 1-5 and comparative examples 1-5
Compositions of invention examples (IE) 1-5 and comparative examples (CE) 1-5 were prepared based on the amounts given in Table 2. The amounts are given in%by weight of active ingredient relative to the total weight of the composition.
Preparation process:
The compositions listed above were prepared as follows, taking the composition of invention example 1 as an example:
1) . adding xanthan gum, diutan gum, and sodium hyaluronate into water of 50℃ in a main beaker with stirring;
2) . adding dipotassium glycyrrhizate, magnesium sulfate, and cocos nucifera (coconut) oil into the main beaker with stirring to obtain the composition.
Evaluation
Suspension property
The suspension property of a composition to be tested was evaluated as follows.
About 20g of the sample to be evaluated was put in a centrifugation tube and centrifuged at 900 r/min for 1 hour at room temperature (25℃) .
The centrifuged sample was compared with the original sample in terms of appearance. If the centrifuged sample is identical to the original sample (even phase) , it will be considered as passing the suspension test. If the centrifuged sample is different from the original sample (for example separated into two phases or sediment occurs) , it will be considered as failing for the suspension test.
Noodling risk
The noodling risk of each composition prepared was evaluated by one sensory expert through special gesture as below:
1) apply 0.2 ml sample to be evaluated on a half face;
2) bend the fingers; and
3) glide the knuckles over the subject’s skin using slight pressure.
If no or small amount of noodles (with a size small than 0.5 cm and number of which is fewer than 5 pieces) were observed, then it will be considered that the sample tested pass the noodle test, and if there are medium size or lots of noodles (for example, with size larger than 0.5 cm or number of which is more than 5 pieces) , then it will be considered that the sample tested fails the noodle test.
The results on whether the composition tested pass or failed the suspension test or the noodle test are summarized in Table 3.
Table 3
It can be concluded that the composition of the present invention can pass the suspension test and has no noodling risk.
Claims (14)
- A composition for caring for keratin materials comprising in an aqueous phase:(i) xanthan gum;(ii) at least one sphingan exopolysaccharide; and(iii) at least 0.5 mmol/L of at least one cosmetic active ingredient of salt type, relative to the total volume of the composition.
- Composition according to claim 1, wherein xanthan gum has a viscosity ranging from 800 to 2000 cps for an aqueous composition containing 1%KCl and 1%xanthan gum, as measured at 25℃ using a Brookfield viscometer at 60 rpm.
- Composition according to claim 1, wherein xanthan gum has a molecular weight ranging from 1 000 000 to 50 000 000.
- Composition of any of claims 1 to 3, wherein xanthum gum is present in an amount ranging from 0.05 wt. %to 0.5 wt. %, preferably from 0.15 wt. %to 0.3 wt. %, relative to the total weight of the composition.
- Composition of any of claims 1 to 4, wherein the sphingan exopolysaccharide is selected from gellan, welan and diutan gum, or combination thereof.
- Composition of any of claims 1 to 4, wherein the sphingan exopolysaccharide is diutan gum.
- Composition according to any of claims 1 to 6, wherein the sphingan exopolysaccharide is present in an amount ranging from 0.05 wt. %to 0.3 wt. %, preferably from 0.06 wt. %to 0.2 wt. %, relative to the total weight of the composition.
- Composition according to any of claims 1 to 7, wherein the weight ratio of xanthan gum to the sphingan exopolysaccharide is between 1.3: 1 and 4: 1, preferably between 1.5: 1 and 3: 1.
- Composition according to any of claims 1 to 8, wherein the cosmetic active ingredient of salt type is selected from sodium slats, potassium salts, magnesium salts, zinc salts, or their combinations, for caring for keratin materials.
- Composition according to any of claims 1 to 9, wherein the cosmetic active ingredient of salt type is selected from sodium hyaluronate, sodium pyrrolidone carboxylate, sodium lactate, sodium ascorbate phosphate, sodium azulene sulfonate, sodium ascorbate, dipotassium glycyrrhizate, magnesium sulfate, magnesium ascorbyl phophate, zinc gluconate, calcium chloride, or their combinations.
- Composition according to any of claims 1 to 10, wherein the weight ratio of the sphingan exopolysaccharide to the cosmetic active ingredient of salt type is between 0.04: 1 and 0.2: 1, preferably between 0.05: 1 and 0.15: 1.
- Composition according to claim 1, comprising in an aqueous phase, relative to the total weight of the composition:(i) from 0.15 wt. %to 0.3 wt. %of xanthan gum;(ii) from 0.06 wt. %to 0.2 wt. %of diutan gum; and(iii) at least 0.5 mmol/L of at least one cosmetic active ingredient of salt type,wherein the weight ratio of xanthan to the sphingan exopolysaccharide is between 1.3: 1 and 4: 1;the weight ratio of the sphingan exopolysaccharide to the cosmetic active ingredient of salt type is between 0.04: 1 and 0.2: 1.
- Composition according to any of claims 1 to 12, wherein the composition is in the form of an oil-in-water emulsion or a homogeneous hydrous system.
- A non-therapeutic method for caring for keratin materials, comprising applying the composition according to any of claims 1 to 13 to the keratin materials.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2022/134956 WO2024113150A1 (en) | 2022-11-29 | 2022-11-29 | Composition for caring for keratin materials |
FR2300586A FR3142354A1 (en) | 2022-11-29 | 2023-01-23 | COMPOSITION FOR THE CARE OF KERATIN MATERIALS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2022/134956 WO2024113150A1 (en) | 2022-11-29 | 2022-11-29 | Composition for caring for keratin materials |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024113150A1 true WO2024113150A1 (en) | 2024-06-06 |
Family
ID=91196783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/134956 WO2024113150A1 (en) | 2022-11-29 | 2022-11-29 | Composition for caring for keratin materials |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3142354A1 (en) |
WO (1) | WO2024113150A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104066422A (en) * | 2011-11-25 | 2014-09-24 | 欧莱雅 | Tinted emulsion |
WO2017206047A1 (en) * | 2016-05-31 | 2017-12-07 | L'oreal | Translucent sunscreen composition with improved uv screening ability |
US20190125650A1 (en) * | 2017-10-31 | 2019-05-02 | L'oreal | Hair care compositions |
WO2019080005A1 (en) * | 2017-10-25 | 2019-05-02 | L'oreal | A composition for caring for skin, method and use thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105456052A (en) * | 2015-12-25 | 2016-04-06 | 肇庆迪彩日化科技有限公司 | Skin care composition |
CN108210357A (en) * | 2016-12-16 | 2018-06-29 | 广州市索柔生物科技有限公司 | A kind of multiple-effect water conservation spraying facial mask |
CN108420764A (en) * | 2018-05-12 | 2018-08-21 | 佛山云裳化妆品有限公司 | It is a kind of enhancing skin elasticity skin care compositions and its application |
KR20230044488A (en) * | 2020-08-05 | 2023-04-04 | 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 | Emulsifier composition for personal care formulations |
KR20230098574A (en) * | 2020-10-21 | 2023-07-04 | 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 | Enhanced Deposition Compositions for Personal Care Actives |
CN112263528A (en) * | 2020-10-26 | 2021-01-26 | 广东美集科技有限公司 | Collagen jelly mask and preparation and use methods thereof |
CN115463075A (en) * | 2022-09-30 | 2022-12-13 | 广州市婷采化妆品有限公司 | Anti-wrinkle firming composition skin care product and preparation method thereof |
-
2022
- 2022-11-29 WO PCT/CN2022/134956 patent/WO2024113150A1/en unknown
-
2023
- 2023-01-23 FR FR2300586A patent/FR3142354A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104066422A (en) * | 2011-11-25 | 2014-09-24 | 欧莱雅 | Tinted emulsion |
WO2017206047A1 (en) * | 2016-05-31 | 2017-12-07 | L'oreal | Translucent sunscreen composition with improved uv screening ability |
WO2019080005A1 (en) * | 2017-10-25 | 2019-05-02 | L'oreal | A composition for caring for skin, method and use thereof |
CN111246831A (en) * | 2017-10-25 | 2020-06-05 | 莱雅公司 | Compositions, methods and uses for treating skin |
US20190125650A1 (en) * | 2017-10-31 | 2019-05-02 | L'oreal | Hair care compositions |
Also Published As
Publication number | Publication date |
---|---|
FR3142354A1 (en) | 2024-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106176286B (en) | Hyaluronic acid skin nursing film and preparation method and application | |
KR102394532B1 (en) | Cosmetic composition containing hyaluronic acids having different molecular weight | |
CN101952325A (en) | Crosslinked hyaluronic acid in emulsion | |
EP3081232A1 (en) | Hyaluronic acid gel composition having sustained release property | |
JPWO2006093175A1 (en) | Fucoidan production method, fucoidan and fucoidan-containing composition | |
CN104780902A (en) | Composition for external use | |
Campos et al. | Effects of polysaccharide-based formulations on human skin | |
JP5989226B2 (en) | Gel-like composition for skin | |
WO2024113150A1 (en) | Composition for caring for keratin materials | |
EP1317489B1 (en) | A mixture of non-sulfated fucose-based oligosaccharides, a cosmetic or pharmaceutical composition comprising said mixture and its use in cosmetics or pharmacy | |
JP2012092022A (en) | External skin patch | |
CN106361595A (en) | Zhiyan introduced solvent essence | |
JP2001233755A (en) | Skin care preparation composition | |
CN107485598B (en) | It is a kind of to thicken pearl toner and preparation method thereof certainly | |
WO2021212267A1 (en) | Composition for caring for the skin | |
WO2021077320A1 (en) | Composition for caring for the skin | |
CA2424830C (en) | Composition comprising fucose and vitamin c and/or vitamin a | |
JP6247043B2 (en) | Cosmetics and external preparation for skin | |
CN115916138A (en) | Oil-containing cleaning compositions | |
WO2020130153A1 (en) | Cosmetic compositions with visible droplets comprising polysaccharides and metal salt | |
JP2004083484A (en) | Skin external preparation | |
CN1285193A (en) | preparing and application of oral hyaluronic acid skin-beautifying health care preparation | |
CN115768397A (en) | Gelling compositions comprising short chain fatty acid salts | |
CN105769602A (en) | Safe and multivitamin compounded freckle-removing cream and preparation method thereof | |
FR2813789A1 (en) | Composition used for cosmetic treatment of skin comprises vitamin C and/or vitamin A and fucose component |